Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranolazine in Cardiac Ischaemia from Chronic Total Occlusions
NCT02423265Phase 4Withdrawn
- Sponsor
- East Carolina University
- Start
- Jun 2015
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ranolazine in Myocardial ischemia (MI), coronary artery disease (CAD), arteriosclerosis, angina pectoris, sponsored by East Carolina University. Planned start Jun 2015; status: withdrawn.
02
Drugs
ranolazine
03
Conditions
Myocardial ischemia (MI)coronary artery disease (CAD)arteriosclerosisangina pectoris
Beyond the preview
Go deeper on NCT02423265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02423265.